O	0	12	Mammographic
O	13	20	density
O	21	27	change
O	28	32	with
O	33	34	1
O	35	39	year
O	40	42	of
B-intervention	43	50	aerobic
I-intervention	51	59	exercise
O	60	65	among
O	66	80	postmenopausal
O	81	86	women
O	86	87	:
O	88	89	a
O	90	100	randomized
O	101	111	controlled
O	112	117	trial
O	117	118	.

O	119	122	The
O	123	130	Alberta
O	131	139	Physical
O	140	148	Activity
O	149	152	and
O	153	159	Breast
O	160	166	Cancer
O	167	177	Prevention
O	178	179	(
O	179	184	ALPHA
O	184	185	)
O	186	191	Trial
O	192	200	examined
O	201	204	the
O	205	214	influence
O	215	217	of
O	218	225	aerobic
O	226	234	exercise
O	235	237	on
O	238	248	biological
O	249	256	factors
O	257	261	that
O	262	265	are
O	266	276	associated
O	277	281	with
O	282	288	breast
O	289	295	cancer
O	296	300	risk
O	300	301	.

O	302	314	Mammographic
O	315	322	density
O	322	323	,
O	324	325	a
O	326	335	secondary
O	336	343	outcome
O	343	344	,
O	345	347	is
O	348	356	reported
O	357	361	here
O	361	362	.

O	363	366	The
O	367	372	ALPHA
O	373	378	Trial
O	379	382	was
O	383	384	a
O	385	393	parallel
O	394	399	group
O	400	410	randomized
O	411	421	controlled
O	422	427	trial
O	428	437	conducted
O	438	445	between
O	446	449	May
O	450	454	2003
O	455	458	and
O	459	463	July
O	464	468	2007
O	468	469	.

B-eligibility	470	484	Postmenopausal
I-eligibility	484	485	,
I-eligibility	486	495	sedentary
I-eligibility	496	501	women
O	502	506	ages
B-age	507	509	50
I-age	510	512	to
I-age	513	515	74
I-age	516	521	years
O	522	523	(
O	523	524	n
O	525	526	=
B-total-participants	527	530	320
O	530	531	)
O	532	536	were
O	537	543	evenly
O	544	554	randomized
O	555	557	to
O	558	565	aerobic
O	566	574	exercise
O	575	576	(
O	576	578	45
O	579	586	minutes
O	586	587	,
O	588	589	5
O	590	594	days
O	595	598	per
O	599	603	week
O	603	604	)
O	605	607	or
B-control	608	615	control
I-control	616	617	(
I-control	617	622	usual
I-control	623	627	life
I-control	627	628	-
I-control	628	633	style
I-control	633	634	)
O	635	638	for
O	639	640	1
O	641	645	year
O	645	646	.

O	647	652	Dense
O	653	667	fibroglandular
O	668	674	tissue
O	675	678	and
O	679	687	nondense
O	688	693	fatty
O	694	700	tissue
O	701	705	were
O	706	714	measured
O	715	719	from
O	720	730	mammograms
O	731	733	at
O	734	742	baseline
O	743	746	and
O	747	748	1
O	749	753	year
O	754	759	using
O	760	768	computer
O	768	769	-
O	769	777	assisted
O	778	790	thresholding
O	791	799	software
O	800	803	for
O	804	808	area
O	809	821	measurements
O	822	825	and
O	826	827	a
O	828	831	new
O	832	841	technique
O	842	846	that
O	847	853	relies
O	854	856	on
O	857	860	the
O	861	872	calibration
O	873	875	of
O	876	887	mammography
O	888	893	units
O	894	898	with
O	899	900	a
O	901	907	tissue
O	907	908	-
O	908	918	equivalent
O	919	926	phantom
O	927	930	for
O	931	941	volumetric
O	942	954	measurements
O	954	955	.

B-outcome	956	964	Nondense
I-outcome	965	971	volume
O	972	981	decreased
O	982	984	in
O	985	988	the
O	989	997	exercise
O	998	1003	group
O	1004	1012	relative
O	1013	1015	to
O	1016	1019	the
O	1020	1027	control
O	1028	1033	group
O	1034	1035	(
O	1035	1045	difference
O	1046	1053	between
O	1054	1060	groups
O	1061	1062	=
O	1063	1064	-
O	1064	1066	38
O	1066	1067	.
O	1067	1068	5
O	1069	1071	cm
O	1071	1072	(
O	1072	1073	3
O	1073	1074	)
O	1074	1075	;
O	1076	1078	95
O	1078	1079	%
O	1080	1090	confidence
O	1091	1099	interval
O	1099	1100	,
O	1101	1102	-
O	1102	1104	61
O	1104	1105	.
O	1105	1106	6
O	1107	1109	to
O	1110	1112	15
O	1112	1113	.
O	1113	1114	4
O	1114	1115	;
O	1116	1117	P
O	1118	1119	=
O	1120	1121	0
O	1121	1122	.
O	1122	1125	001
O	1125	1126	)
O	1126	1127	.

B-outcome	1128	1135	Changes
I-outcome	1136	1138	in
I-outcome	1139	1144	total
I-outcome	1145	1149	body
I-outcome	1150	1153	fat
O	1154	1163	accounted
O	1164	1167	for
O	1168	1172	this
O	1173	1181	decrease
O	1181	1182	.

B-outcome	1183	1190	Changes
I-outcome	1191	1193	in
I-outcome	1194	1199	dense
I-outcome	1200	1204	area
I-outcome	1205	1208	and
I-outcome	1209	1214	dense
I-outcome	1215	1221	volume
O	1221	1222	,
O	1223	1231	measures
O	1232	1236	that
O	1237	1241	have
O	1242	1252	previously
O	1253	1257	been
O	1258	1268	associated
O	1269	1273	with
O	1274	1280	breast
O	1281	1287	cancer
O	1288	1292	risk
O	1292	1293	,
O	1294	1298	were
O	1299	1302	not
O	1303	1316	significantly
O	1317	1326	different
O	1327	1334	between
O	1335	1338	the
O	1339	1345	groups
O	1346	1347	(
O	1347	1348	P
O	1349	1350	>
O	1351	1353	or
O	1354	1355	=
O	1356	1357	0
O	1357	1358	.
O	1358	1360	26
O	1360	1361	)
O	1361	1362	.

O	1363	1372	Achieving
O	1373	1380	changes
O	1381	1383	in
O	1384	1396	mammographic
O	1397	1405	measures
O	1406	1409	may
O	1410	1417	require
O	1418	1422	more
O	1423	1431	exercise
O	1432	1434	or
O	1435	1436	a
O	1437	1442	study
O	1443	1453	population
O	1454	1458	with
O	1459	1465	higher
O	1466	1474	baseline
O	1475	1481	levels
O	1482	1484	of
O	1485	1488	sex
O	1489	1497	hormones
O	1498	1500	or
O	1501	1502	a
O	1503	1508	wider
O	1509	1514	range
O	1515	1517	of
O	1518	1530	mammographic
O	1531	1538	density
O	1538	1539	.

O	1540	1543	The
O	1544	1548	data
O	1549	1553	from
O	1554	1558	this
O	1559	1564	study
O	1564	1565	,
O	1566	1573	however
O	1573	1574	,
O	1575	1582	suggest
O	1583	1587	that
O	1588	1591	the
O	1592	1602	protective
O	1603	1609	effect
O	1610	1612	of
O	1613	1621	exercise
O	1622	1624	on
O	1625	1631	breast
O	1632	1638	cancer
O	1639	1643	risk
O	1644	1647	may
O	1648	1655	operate
O	1656	1663	through
O	1664	1665	a
O	1666	1675	mechanism
O	1676	1681	other
O	1682	1686	than
O	1687	1699	mammographic
O	1700	1707	density
O	1707	1708	.
